Table 2_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.xlsx

Table 2_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.xlsx

Objective<p>Silicosis is characterized by silicon nodules and diffuse pulmonary fibrosis. To date, no effective therapy has been developed for the treatment of silicosis. This study aimed to investigate the effects of Galunisertib, a TGF-β receptor I kinase inhibitor, on the autophagy-lysosome...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Rou Li (11575418) (author)
Altres autors: Huimin Kang (435951) (author), Aoxiang Hu (22679153) (author), Guo Chen (182090) (author), Tinghua Yan (18786622) (author), Ting Liu (45625) (author), Shi Chen (120917) (author)
Publicat: 2025
Matèries:
Pharmacology
Galunisertib
silicosis
TGF-β
autophagy
fibrosis
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

Ítems similars